Fine particulate matter (PM2.5) promotes IgE-mediated mast cell activation through ROS/Gadd45b/JNK axis

Ying Wang1, Ni Tang1, Manyun Mao1

  • 1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China; Hunan Engineering Research Center of Skin Health and Disease, Changsha, China.

Abstract

Insights

Fine particulate matter (PM2.5) exposure worsens allergic diseases by activating mast cells. PM2.5 triggers reactive oxygen species (ROS) production via the Gadd45b/MEKK4/JNK pathway, enhancing allergic responses.

Area of Science:

  • Immunology
  • Environmental Health
  • Cell Biology

Background:

  • Mast cells are crucial in allergic reactions.
  • Chronic exposure to fine particulate matter (PM2.5) exacerbates allergic diseases, but mechanisms are unclear.

Purpose of the Study:

  • To investigate how PM2.5 affects IgE-mediated mast cell responses.
  • Utilized an IgE-mediated mouse model and mast cell activation assays.

Main Methods:

  • Assessed IgE-mediated mast cell activation in vitro and in vivo using beta-hexosaminidase release and passive cutaneous anaphylaxis (PCA) models.
  • Analyzed gene expression profiles with RNA-Seq, measured reactive oxygen species (ROS) via flow cytometry, and examined protein expression using RT-PCR, Western Blot, and ELISA.

Main Results:

  • PM2.5 enhanced IgE-mediated mast cell degranulation and cytokine production, increasing vascular permeability and serum cytokines in mice.
  • PM2.5 upregulated Gadd45b, activating the MEKK4/JNK pathway and increasing ROS levels.
  • Gadd45b knockdown and JNK inhibition significantly reduced PM2.5-induced mast cell activation and cytokine release.

Conclusions:

  • PM2.5 promotes ROS production, which activates the Gadd45b/MEKK4/JNK pathway.
  • This pathway facilitates IgE-mediated mast cell activation, contributing to allergic disease exacerbation.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Allergic Reactions02:06

Allergic Reactions

Overview
30.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
953
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Inflammation01:38

Inflammation

Overview
57.6K